The TRANSFORM-2 trial found Spravato patients were 70% more likely to achieve remission than those receiving an antidepressant plus placebo, with statistically significant improvement at 24 hours
Spravato Treatment in Lazybrook, Houston TX
Catalyst Health & Wellness serves Lazybrook patients — and those from Timbergrove, Heights, Garden Oaks, Oak Forest, and the TC Jester corridor — with FDA-approved Spravato (esketamine) therapy at three Houston locations, administered by Dr. Ho, board-certified anesthesiologist and former pediatrician. Brigham and Women’s Faulkner Hospital in Boston notes that esketamine “offers a modality of treatment for people who have had an inadequate response to standard antidepressants and other neurotherapeutic treatments of depression.” That modality is available now, close to home, at a clinic you can reach from Lazybrook in under 15 minutes. Three Houston locations open Monday–Sunday, 5am–9pm.
Breakthrough Spravato Treatment Near Lazybrook
There’s something particular about the way treatment-resistant depression affects people in close-knit, community-oriented neighborhoods like Lazybrook. The civic meetings. The neighbor you’ve known for a decade. The block where everyone still waves. Depression can hollow out your capacity for all of it, quietly and without announcement — until what should feel like connection feels like performance, and what should feel like home feels like a set you’re moving through.
Lazybrook sits just minutes from the Heights on Loop 610 — which means Catalyst’s Heights clinic at 104 W. 12th Street is as accessible as any appointment in the neighborhood. Spravato (esketamine) is the first FDA-approved antidepressant in over three decades to operate through a genuinely different mechanism. Where every prior antidepressant adjusted monoamine neurotransmitters — serotonin, norepinephrine, dopamine — Spravato targets glutamate via the NMDA receptor. The downstream effect: BDNF production, mTOR activation, synaptogenesis. Not chemical adjustment. Structural repair, beginning within hours of the first dose.
Brigham and Women’s Faulkner Hospital’s clinical team frames the realistic picture honestly: “50 to 70 percent of patients will have a clinically significant response to the treatment.” That’s a meaningful probability of response for patients with a history of inadequate outcomes. For the Lazybrook resident who’s done everything right and still hasn’t broken through — that number represents real, grounded hope, not a guarantee.
What is Spravato Therapy?
approval — a status reserved for treatments showing early evidence of substantial improvement over existing options for serious conditions. Conventional antidepressants achieved that original 2019 approval by demonstrating that a fundamentally different mechanism could work where monoamine-based pharmacology had not. The FDA extended Spravato’s approval in 2020 to adults with MDD and active suicidal ideation, and in January 2025 made a third significant decision: approving esketamine as a standalone monotherapy — the first medication ever cleared to treat TRD without requiring a concurrent oral antidepressant.
Research consistently shows powerful results:
What Our Patients Say
Take the First Step Toward Healing
Book Appointment
Conditions We Treat with Spravato Therapy Near Lazybrook
Spravato holds FDA approval for two specific clinical indications. At Catalyst Health & Wellness, we offer it for:
Your Spravato Therapy Journey at Catalyst Health & Wellness
Every step has been structured so that Lazybrook patients with full lives can actually complete treatment without it becoming another source of friction.
Step 1: Free Phone Consultation
No charge, no commitment. A clinical team member discusses your full history — medications tried, durations, outcomes, current circumstances — and gives you an honest assessment of whether Spravato is the appropriate next step for your situation. If it isn’t, you’ll hear that directly.
Step 2: Insurance Verification & Prior Authorization
Most major commercial plans and Medicare cover Spravato for qualifying TRD patients. Prior authorization is essentially required universally. Our team handles the entire process: benefits verification, clinical documentation, submission, insurer follow-up, and appeals when needed. You’ll know your coverage status before any appointment is scheduled.
Step 3: Before Your First Visit
We walk through every practical detail in advance: dietary timing (nothing to eat for 2 hours before, no liquids for 30 minutes), what to bring, transportation requirements, and any medication timing notes from your current regimen.
Step 4: Day of Treatment
Budget approximately two to two-and-a-half hours. Driving is not permitted on treatment days — every appointment requires a designated driver or pre-arranged rideshare.
Step 5: Your Treatment Session
You’ll use the nasal spray yourself, in a private treatment room, under Dr. Ho’s direct clinical supervision — continuous monitoring of vital signs, blood pressure, and response throughout. The room is purpose-built: reclinable chair, controlled lighting, warm blankets, noise-cancelling headphones. Temporary dissociation, if it occurs, peaks around 40 minutes post-dose and resolves within two hours. Brigham and Women’s notes that this experience is best understood as “part of the broader tapestry of recovery” — one component of a process, not the defining feature of it.
Step 6: Recovery & Aftercare
After monitoring, you leave with your driver. No driving until the morning after a full night’s sleep. Between sessions, our team follows up on your response and adjusts anything before your next visit.
Step 7: Treatment Schedule & Maintenance
Twice weekly in weeks 1–4. Once weekly in weeks 5–8. Then individualized maintenance — weekly, biweekly, or monthly — based on your actual response trajectory. The frequency is calibrated to you, not a default protocol.
The Science Behind Spravato for Treatment-Resistant Depression
The evidence base spans two pivotal phase 3 trials, a 2025 monotherapy study, and nearly six years of real-world post-approval safety data reviewed by the FDA and regulators in over 77 countries.
The TRANSFORM-2 study (American Journal of Psychiatry) enrolled TRD patients in a double-blind comparison of flexibly-dosed Spravato plus a newly initiated oral antidepressant versus antidepressant plus placebo. Spravato patients were 70% more likely to achieve remission. Statistically significant improvement was measured at 24 hours — produced by the NMDA-driven BDNF/mTOR/synaptogenesis cascade that conventional antidepressants, which never engage NMDA receptors, don’t initiate. Brigham and Women’s Faulkner Hospital’s Benjamin Yudkoff, MD, notes that “as a person experiences an inadequate response to sequential antidepressants, the likelihood the next will work decreases” — the exact clinical trajectory that Spravato’s different mechanism is designed to interrupt.
The SUSTAIN-1 trial (JAMA Psychiatry) established durability: hazard ratio of 0.49 for time to relapse in maintained patients versus those transitioned to placebo (p=0.003). Brigham and Women’s also reports that “50 to 70 percent of patients will have a clinically significant response” in practice — a real-world probability range that gives the phase 3 efficacy data clinical translation.
Key research findings:
- Esketamine is the pure levorotatory enantiomer of ketamine — its higher NMDA receptor affinity enables antidepressant effect at lower doses and through intranasal delivery, facts Brigham and Women’s explains in specific molecular terms
- ASPIRE I and II trials confirmed significant depressive symptom reduction within 24 hours in patients with MDD and active suicidal ideation — the only FDA-approved rapid pharmacological option for that population
- Real-world data from the REMS safety database covering 2019–2024 confirmed no new safety signals across more than 58,000 patients treated worldwide
- The January 2025 FDA monotherapy approval adds a new treatment pathway, expanding eligibility for patients who need or prefer to use Spravato without a concurrent oral antidepressant
Why Choose Catalyst Health & Wellness for Spravato Treatment Near Lazybrook
01
REMS-Certified Provider
FDA REMS certification is required for every Spravato treatment setting. Catalyst holds full certification at all three Houston locations, including the Heights clinic at 104 W. 12th Street — under 15 minutes from Lazybrook via Loop 610 and TC Jester. Every session meets every federal safety standard. For patients managing twice-weekly appointments during the induction phase, the short drive genuinely matters.
02
Dr. Ho: The Right Credentials for This Medication
Esketamine is an NMDA receptor antagonist derived from an anesthetic. Dr. Ho’s board certification in anesthesiology places him among the small subset of physicians who understand this compound pharmacologically rather than just clinically. He knows esketamine’s behavior inside the body, not just its label indications. That depth of knowledge translates directly to the quality of dosing decisions and monitoring judgment during every session. His prior career as a pediatrician ensures the care culture is patient-centered and attentive in a way that clinical precision alone doesn’t guarantee.
03
Insurance Navigation
Prior authorization for Spravato involves specific documentation requirements that vary by insurer. Our team has navigated this across dozens of commercial plans. We verify benefits, prepare documentation, submit the prior auth, follow up with the insurer, and appeal when necessary. You’ll have a confirmed coverage status before the first session. You should be focused on treatment, not paperwork.
04
Whole-Person Approach
Our team engages with the specifics: which medications you tried, for how long, at what doses, what the outcomes were, and what your current life actually looks like. Treatment plans are built around that complete picture and updated as your response evolves. We coordinate with your existing prescriber or psychiatrist rather than operating as a parallel system.
05
Extended Hours & Flexible Scheduling
Each session requires two or more hours in clinic. For Lazybrook and Heights-area residents managing jobs, families, and the rhythms of a neighborhood where community involvement matters, the 5am to 9pm hours at all three Houston locations mean treatment doesn’t require sacrificing something else. Pre-dawn appointments, evening sessions, weekends — all available, all week, every week.
06
Comprehensive Treatment Options
Spravato is a powerful tool, but it’s not the only one. When your clinical picture benefits from a multi-modal approach, Catalyst offers complementary evidence-based treatments under the same roof:
Ketamine Therapy
Broader applications including anxiety, PTSD, chronic pain, OCD, and bipolar depression
TMS Therapy
Non-invasive magnetic brain stimulation for depression and OCD
Stellate Ganglion Block
Targeted nerve block treatment for PTSD and anxiety
Our goal is to find the right combination of treatments for your unique situation — not to fit you into a one-size-fits-all protocol.
07
Safe, Comfortable Environment
Our treatment rooms were designed specifically for the Spravato experience — not repurposed from other clinical uses. Each is private, quiet, and carefully arranged: reclinable chairs, soft adjustable lighting, warm blankets, noise-cancelling headphones. Dr. Ho’s clinical team is present and monitoring throughout every session. You’re observed, supported, and never alone.
Getting Started with Spravato Treatment Near Lazybrook
Lazybrook chose to stay itself while the city grew around it — deed restrictions intact, community meetings still happening, neighbors who know each other’s names. If treatment-resistant depression has been eroding your capacity to be fully present in that kind of community, Spravato offers a clinically grounded path to recovery that’s closer than you might have realized.
Call 800-772-1242 for a free consultation. We’ll review your history, answer every question honestly, and give you a clear clinical picture of whether Spravato makes sense for your situation — nothing more, nothing less.
The Heights clinic is minutes from Lazybrook. Appointments start at 5am and run until 9pm. Dr. Ho and the Catalyst team are ready when you are.
Monday-Sunday, 6am-9pm
Free consultation
Insurance assistance
Three Houston locations
REMS-certified provider
Commonly Asked Questions
Get Help NowHow quickly does Spravato therapy work?
Many patients notice improvements within hours or days of their first treatment. The TRANSFORM-2 study showed significant improvement compared to placebo within 24 hours. This rapid action is one of Spravato’s most remarkable qualities, especially compared to traditional antidepressants that can take 4 to 8 weeks to work.
Is Spravato therapy safe?
Yes, when administered by trained medical professionals in a REMS-certified setting. Spravato underwent extensive clinical trials before FDA approval. Common side effects like dissociation, dizziness, and temporary blood pressure increases typically resolve within 1-2 hours. We monitor your vital signs throughout treatment to ensure your safety.
How many treatments will I need?
During the first month, you’ll receive Spravato twice weekly. In the second month, treatment typically decreases to once weekly. After that, most patients continue with maintenance treatments once weekly or every two weeks. The exact frequency depends on your individual response. We’ll work with you to find the schedule that keeps you feeling your best.
What does Spravato treatment feel like?
Experiences vary from person to person. Many patients describe feeling relaxed, calm, or somewhat disconnected from their surroundings. Some people experience mild visual or sensory changes. These effects are temporary and typically resolve within 1-2 hours after treatment ends. Most patients find the experience manageable and therapeutic.
Can I drive after a Spravato treatment?
No, you cannot drive yourself home after Spravato treatment, and you should not drive until the next day after a restful night’s sleep. You’ll need to arrange transportation both to and from your appointment. By the time you leave our facility after the 2-hour observation period, you’ll feel much clearer, but driving remains unsafe until the following day.
Will my insurance cover Spravato?
Many insurance plans cover Spravato for qualifying patients since it’s FDA-approved for treatment-resistant depression. Coverage varies by plan and typically requires prior authorization. Our team handles the insurance process for you, including benefits verification and prior authorization submissions.
Can I continue my current medications?
Spravato is always used alongside an oral antidepressant, so you’ll continue taking your prescribed antidepressant medication. We’ll coordinate with your prescribing physician to ensure your overall treatment plan is optimized. Some medications may require adjustment before starting Spravato, which we’ll discuss during your consultation.
Do I need a referral from my doctor?
No, you don’t need a referral to begin Spravato therapy at Catalyst Health & Wellness. However, coordination with your current prescribing physician is important since Spravato must be used alongside an oral antidepressant. We encourage communication between all members of your healthcare team.
Our Locations
Blog & insight
Insights on Healing, Growth, and Mental Wellness
June 13, 2026
FAQ: Common Questions About Ketamine Treatment Answered
If you've been researching ketamine therapy in Houston, chances are you've come across a lot of conflicting information. One article calls it a miracle cure. Another paints it as a risky party drug. Somewhere in between sits the truth, and you deserve straightforward answers before making any decision about your mental health or chronic pain…
June 10, 2026
Can Ketamine Therapy Help with Both Depression and Anxiety?
If you've spent years battling depression only to find anxiety creeping in alongside it (or vice versa), you're not imagining the connection. These two conditions show up together far more often than people realize, and the overlap can make recovery feel like trying to untangle a knot that keeps tightening. Traditional antidepressants and anti-anxiety medications…
June 7, 2026
Neuropathic Pain and Ketamine: Relief When Nerve Pain Won’t Quit
If you live with neuropathic pain, you already know it doesn't behave like ordinary pain. It burns when nothing touched you. It shocks down your leg while you're sitting still. It turns the brush of a bedsheet into something sharp. And the medications your doctor prescribed, the gabapentin, the duloxetine, maybe even opioids, take the…
Make an Appointment
Our mission is to empower individuals to overcome life’s challenges through professional psychological support.